// App-Quantinova.ai

AB1029 (2018) : Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART study: baseline characteristics of the randomised patient population

Researchers

Presenter

  • I. Mackenzie

Principal Investigators

  • I. Ford

  • C. Hawkey

  • A. Begg

  • J. Taggar

  • A. Struthers

  • L. Wei

  • A. Avery

  • A. Walker

  • S. Duce

  • R. Barr

  • J. Dumbleton

  • T. MacDonald

Medical Centers

  • MEMO Research, University of Dundee, Dundee

  • Robertson Centre of Biostatistics, University of Glasgow, Glasgow, United Kingdom

  • University of Nottingham, Nottingham, United Kingdom

  • Townhead Medical Practice, Montrose

  • University of Dundee, Dundee, UK

  • University College London, London, UK

  • EScience, University of Glasgow, Glasgow, UK

Locations

  • South Africa

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • National Institute for Health and Care Research

Result

  • N/A